KYNB Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)2.96
Revenue Actual (USD)-1.47M
FibroGen Ord Shs Earnings Dates & Reports
This page offers detailed FibroGen Ord Shs earnings data including the latest FibroGen Ord Shs earnings report, the upcoming FibroGen Ord Shs earnings date, historical data and FibroGen Ord Shs earnings call news.
KYNB Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
KYNB FY2025 Earnings
EPS (YoY)45.38481.64%
Revenue (YoY)6.44M-78.26%
FibroGen Ord Shs (KYNB) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | 2.96/-3.18 | -1.47M/2.01M | 192.93% | -173.46% |
| 5/12/2026 | 03/2026 | -3.76/-3.35 | 3.74M/1.31M | -11.93% | 185.34% |
| 3/16/2026 | 12/2025 | -3.51/-3.88 | 1.28M/1.43M | 9.53% | -10.39% |
| 11/10/2025 | 09/2025 | 49.61/-4.00 | 1.08M/1.64M | 1338.78% | -34.39% |
FibroGen Ord Shs Latest Earnings Call Transcripts
KYNB Q2 2026 Earnings Call: $95.7M Liquidity and Q4 Clinical Catalysts
KYNB’s Q2 2026 earnings call covered $95.7 million in liquidity, a runway into 2028 and Q4 catalysts for FG-3246 and roxadustat.